USP General Chapter <1079> Pharmacopeia Forum. for Drug Products
|
|
- Angel Benson
- 6 years ago
- Views:
Transcription
1 USP General Chapter <1079> Pharmacopeia Forum Good Storage and Transportation Practices for Drug Products IATA Vancouver/March 8-12, 2010 Mary Foster, PharmD USP Expert Committee Member, Packaging, Storage and Transportation Vice President, Quality Catalent Pharma Solutions, Inc. 30
2 Agenda Introduction to <1079> Themes Systems Approach Practices to Support Drug Product Integrity Accountability Throughout Chain of Custody Transparency Throughout Chain of Custody How To Use Guide 31
3 Introduction to Revised General Chapter <1079> Current Aimed at geographically localized li activities, iti i.e. within NA Discusses distribution chain in separate entities terms Revision in Pharmacopeia Forum Global application and accountability Discusses complexity within distribution chain and links to all entities 32
4 Introduction to Revised of General Chapter <1079> Drug Products (Human; Veterinary; Clinical Trial) Manufacturers, packagers; repackagers; wholesalers; distributors; hospital, mail-order and retail pharmacies Contractor s site; Laboratories Transportation vehicles (aircraft; automobiles; vans; containers; railcars; ships; trucks (large and small) Including Emergency Medical Services (EMS) vehicles and ambulances (removed from USP <1070>) Mail distributors (postal services; expedited mail services, e.g. DHL; FedEx) Excludes APIs & excipients, however 33
5 Themes <1079> Systems To provide a management systems approach Life-cycle management based on science, evidence & justification Improve efficiency in the supply chain Definitions to the systems in the context of storage & transportation Quality System Storage System Environmental System Transportation System Risk System 34
6 Themes <1079> Practices To provide a management systems approach To recommend standard practices including controls and SOPs All drugs - not just cold chain All operational space All entities ttes 35
7 Themes <1079> Accountability To provide a management systems approach To recommend standard practices To discuss accountability Ensure drug life-cycle Safety, identity, strength, quality, and purity Joint venture throughout supply chain 36
8 USP General Chapter <1079> Revision Themes Good Storage and Transportation Practices for Drug Products Systems Practices Accountability 37
9 USP General Chapter <1079> Revision Themes Good Storage and Transportation Practices for Drug Products Systems Practices Accountability 38
10 Systems Approach Systems Quality System (QMS) Storage System (SMS) Environmental System (EMS) Risk System (RMS) Transportation System (TMS) 39
11 Systems Approach Systems Quality System (QMS) Storage System (SMS) Environmental System (EMS) Transportation System (TMS) <1079> QMS Risk System (RMS) Set of policies, processes & procedures (SOPs) that enable the identification, measurement, control and improvement of the storage and transportation of drug product Defined roles and responsibilities Purposefully building documented alliances [e.g., Quality Agreements or Collaborative Agreements] 40
12 Systems Approach Systems Quality System (QMS) <1079> QMS = Set of policies, processes & procedures that enable the identification, measurement, control and improvement of the storage and transportation of drug product SOPs/Defined roles/collaborative Agreements Establish load configurations in cargo hold areas Sub-contracted or non-dedicated vehicles used in airport transportation to/from aircraft Document deviations and investigations to defined root cause(s) Transparent change control Self inspections; corporate audits; allow customer audits? 41
13 Systems Approach Systems Quality System (QMS) <1079> QMS = Set of policies, processes & procedures that enable the identification, measurement, control and improvement of the storage and transportation of drug product SOPs/Defined roles/collaborative Agreements Measuring key elements to ensure procedures are adequately followed from receipt to delivery Controlling critical parameters to ensure storage and transportation conditions have been appropriate while in their control Understand requirements of all relative drug regulatory agencies within own country; and, global regulatory agency 42
14 Systems Approach Systems Quality System (QMS) Environmental System (EMS) Storage System (SMS) Transportation System (TMS) Risk System (RMS) <1079> EMS A section of the QMS that covers environmental controls, including an adequate organization structure, roles & responsibilities, SOPs/policies/standards and processes for developing and maintaining an environmental program 43
15 Systems Approach Systems Environmental System (EMS) <1079> EMS = A section of the QMS that covers environmental controls, including an adequate organization structure, roles & responsibilities, SOPs/policies/standards and processes for developing and maintaining an environmental program. Environmental controls/roles/sops Over the life-cycle stability profile of products - airline time included Building stability profiles that cover potential excursions based on travel - airline cargo areas; tarmacs; airline hold areas Resolutions to CAPA s; preventive programs put in place (e.g., alert mechanism for temp breaches) Requiring SOPs, documentation and justifications Symbols and icons 44
16 Systems Approach Systems Quality System (QMS) Environmental System (EMS) Storage System (SMS) Transportation System (TMS) <1079> SMS Risk System (RMS) Program to provide continuous improvement in the storage of drug products with key locations Buildings and facilities; vehicles and dispensing areas Basic processes Receiving/transferring; g storage/holding g 45
17 Systems Approach Systems Storage System (SMS) <1079> SMS = Program to provide continuous improvement in the storage of drug products with key locations in buildings and facilities, vehicles and dispensing areas. Storage program locations/processes Assures adequate controls (basics: extremes in temp, fire, water, explosion, pests) Prevent diversion 46
18 Systems Approach Systems Quality System (QMS) Environmental System (EMS) Storage System (SMS) Transportation System (TMS) Risk System (RMS) <1079> TMS Provide continuous improvement of drug product lifecycle by better and more efficient use of transportation processes 47
19 Systems Approach Systems Transportation System (SMS) <1079> TMS = Provide continuous improvement of drug product lifecycle by better and more efficient use of transportation processes Create transportation system that assures adequate product protection ti regardless of location Oversight program with accountability Notification to regulatory authorities Validation or qualification program for a vehicle should represent environmental extremes Temp map report define areas unsuitable; the minimum and maximum time allowances/tolerances 48
20 Systems Approach Systems Quality System (QMS) Environmental System (EMS) Storage System (SMS) Transportation System (TMS) Risk System (RMS) <1079> RMS A section of the QMS that covers the tools for determining how to handle deviations and excursions 49
21 Systems Approach Systems Risk System (SMS) RMS = <1079> A section of the QMS that covers the tools for determining how to handle deviations and excursions Process and SOPs when storage condition is not maintained Procedures when contamination ti is observed, e.g. pests, mold, moisture Security yprocedures Audit of transportation firms 50
22 1 2 3 Systems Practices Accountability 51
23 Standard Practices Practices Storage and Transportation Systems A B Warehouse Storage Hold Areas Vehicles Process Receiving Transferring Storing Holding Transporting Administering C Pharmacies Dispensers D End Users 1 Prevent preparation damage at times of uncontrolled storage. Limit it time out of storage conditions. Monitor and control temperature and act on deviations. 3 4 Determine if temperature mapping is required. Procedures and documentation required. 2 Determine temperature, air flow, and load patterns. Monitor 52and control temperature and act on deviations.
24 Standard Practices Practices Storage and Transportation Systems A B Warehouse Storage Hold Areas Vehicles Process Receiving Transferring Storing Holding Transporting Administering C Pharmacies Dispensers D End Users 1 Prevent preparation damage at times of uncontrolled storage. Limit it time out of storage conditions. Monitor and control temperature and act on deviations. 3 4 Determine if temperature mapping is required. Procedures and documentation required. 2 Determine temperature, air flow, and load patterns. Monitor 53and control temperature and act on deviations.
25 Standard Practices Practices Storage and Transportation Systems A Warehouse Storage Hold Areas B Vehicles - C Process Receiving Transferring Storing Holding Transporting e.g. Aircraft Pharmacies Dispensers Administering D End Users 1 Prevent preparation damage at times of uncontrolled storage. Limit it time out of storage conditions. Monitor and control temperature and act on deviations. 3 4 Determine if temperature mapping is required. Procedures and documentation required. 2 Determine temperature, air flow, and load patterns. Monitor 54and control temperature and act on deviations.
26 Standard Practices Practices Storage and Transportation Systems Process Environmental conditions (temperature, humidity, light) Receiving Storing Transporting Administering controlled and Transferring monitored Holding APreventive Warehouse Maintenance program in place Storage Environmental 4 Hold Areas monitoring i devices routinely calibrated at preset B Vehicles intervals with alert mechanism Communication within supply chain coordinated 2 to determine proper timing for receipt (and conversely be C Pharmacies transported) Dispensers - holidays, weekends or other forms of interruption D End Users Important consideration international shipments - customs stage supply chain 55
27 Systems Practices Accountability 56
28 Accountability and Responsibility Accountability Accountability and responsibility must be maintained from: Manufacturing through Administration Manufacturing Delivery Administration Supply Chain 57
29 Accountability and Responsibility Accountability Accountability and responsibility must be maintained from: Manufacturing through Administration Manufacturing Delivery Administration Supply Chain - Responsible Entity Applicant holder or manufacturer for non-application preparations Transparency: removed time frames from current chapter (upon 2 hours of receipt ) It should follow for API s, excipients 58
30 Accountability and Responsibility Accountability Accountability and responsibility must be maintained from: Manufacturing through Administration Manufacturing Delivery Administration Supply Chain - Responsible Entity Delivery process RECALL - if it is found in any part of the supply chain to be adulterated due to storage/transportation activities, including counterfeiting 59
31 Accountability and Responsibility Accountability Accountability and responsibility must be maintained from: Manufacturing through Administration Manufacturing Delivery Administration Supply Chain - Responsible Entity Administration and End User Entities Key to final safety, identity, strength, quality and purity 60
32 Accountability and Responsibility Accountability Accountability and responsibility must be maintained from: Manufacturing through Administration Manufacturing Delivery Administration Supply Chain - Responsible Entity All entities along the supply chain - ensure they handle appropriately for temperature t and other causes of preparation adulteration 61
33 Concluding Points General Intended to provide guidance on drug product lifecycle practices along the supply chain inclusive of all relative entities and the associated requirements that must be in place to protect preparations Joint venture mentality as an expression of the need for harmonization and transparency across all stakeholders for critical supply chain aspects such as environmental excursions for the benefit of the patient Equally important is to stay current and be ready to change as new solutions evolve 62
Mary G. Foster, PharmD, USP Chair Packaging, Storage & Distribution Expert Committee June 9, 2015, San Francisco
AAPS Mini Symposium Frozen State Storage and Cold Chain Transportation Storage & Shipping of Biopharmaceuticals USP General Chapter Good Distribution Practices Latest Guidance Developments Mary
More informationANSI Homeland Security Standards Panel Global Supply Chain Security Standards and Annual Plenary Meeting
ANSI Homeland Security Standards Panel Global Supply Chain Security Standards and Annual Plenary Meeting Mary G. Foster, PharmD USP Chair, Expert Committee, Packaging, Storage & Distribution Aphena Pharma
More information<1079> Good Storage and Distribution Practices
Good Storage and Distribution Practices Desmond Hunt, Ph.D. Principal Scientific Liaison September 7, 2017 Mexico City, Mexico Good Distribution Practice Activities Suppliers Procuring, holding,
More informationRe: Proposed revisions to USP General Chapter <1079> Good Storage and Distribution Practices For Drug Products
30 September 2011 Scientific Liaison (PS05) Packaging and Storage Expert Committee US Pharmacopeia 12601 Twinbrook Pkwy Rockville MD 20852-1790 Re: Proposed revisions to USP General Chapter Good
More informationFeedback from Inspection Programme
Feedback from Inspection Programme Wholesale Distribution Conference 8 th February 2017 Darren Scully Health Products Distribution Manager Wholesale distribution overview wholesale distribution procure
More informationSummary of Proposed USP General Chapter <1083> Good Distribution Practices Supply Chain Integrity 02/15/2012
Summary of Proposed USP General Chapter Good Distribution Practices Supply Chain Integrity 02/15/2012 This summary was prepared by the Rx-360 Monitoring and Reporting Working Group which tracks
More informationQuality Risk Management: Excipients
Quality Risk Management: Excipients ExcipientFest 2012 Presented by: Londa Ritchey, M.S. Director, Supplier Qualification Global Quality Operations Pfizer, Inc. Agenda Regulatory Environment Material Quality
More informationDr. Abdulrahman Mohammad Al Jassmi Chief Executive Officer Dubai Hospital Dubai Health Authority
CHALLENGES AND OPPORTUNITIES IN COLD CHAIN: HEALTH CARE RELATED DRIVERS Dr. Abdulrahman Mohammad Al Jassmi Chief Executive Officer Dubai Hospital Dubai Health Authority AGENDA Integrating stakeholders
More informationSupplier Oversight PQRI. September Steven Lynn, MS, CMQ/OE Vice President Global Quality Compliance Mylan
Supplier Oversight September 2014 PQRI Steven Lynn, MS, CMQ/OE Vice President Global Quality Compliance Mylan Agenda Mylan Background Setting the Stage with a Scenario Current State Thinking Supplier Qualification
More informationGood Distribution Practices Toolkit. Quality Management System 08 March 2016
Good Distribution Practices Toolkit Quality Management System 08 March 2016 1 Quality Policy GDP, Legal, Environmental, H&S Processes & Systems Resources Risk Assessments 2 Quality Policy & Objectives
More informationBSWH Technician Continuing Education 2016 Part 2: Pharmacy Law - Controlled Substance Security & Drug Supply Chain Security Act (DSCSA) Contact
BSWH Technician Continuing Education 2016 Part 2: Pharmacy Law - Controlled Substance Security & Drug Supply Chain Security Act (DSCSA) Contact Hours: 1.5 Objectives List some strategies regarding safe
More informationQS, GDP (+GMP?) Maintaining the Integrity of The Supply Chain
QS, GDP (+GMP?) Maintaining the Integrity of The Supply Chain Presented by: Karen Ginsbury For IFF 01 March, 2017 Pharma Supply Chain Manufacturer Wholesaler Raw Material Supply Production Transport Warehouse
More informationGood Manufacturing Practices. Single Points of Contact. Surveillance and Monitoring. Good Distribution Practices. Track and Trace System
Single Points of Contact Good Manufacturing Practices Surveillance and Monitoring Good Distribution Practices 10 1 9 Track and Trace System 2 8 3 7 Good Import/ Export Practices 4 6 5 Internet Sales Clinical
More informationHealth Authority Inspection Management. GMP Inspection practices L. Mansolelli, Group Compliance & Auditing June 2012
Health Authority Inspection Management GMP Inspection practices L. Mansolelli, Group Compliance & Auditing June 2012 Abstract As global health authorities align in inspection standards and practices, key
More informationHow are forwarders addressing the demands of shippers for cost effective air distribution of pharmaceuticals?
How are forwarders addressing the demands of shippers for cost effective air distribution of pharmaceuticals? An introduction to Pharmafreight 1 2 3 4 5 6 7 Established back in 2001 Part of Mach 2 Group
More informationFrancisco Rizzuto IATA Cargo Manager for Western Europe Specialized in Temperature Controlled Shipments for Pharmaceuticals
Francisco Rizzuto IATA Cargo Manager for Western Europe Specialized in Temperature Controlled Shipments for Pharmaceuticals Pharma Process Forum BCN, October 28 th 205 Q3 205 2 The International Air Cargo
More informationPractical and Value Generating Approach to IATA Chapter 17 7 th Edition of the Perishable Cargo Regulations -- David Y. Bang
Practical and Value Generating Approach to IATA Chapter 17 7 th Edition of the Perishable Cargo Regulations -- David Y. Bang With much anticipation and efforts by those who work daily with perishable cargo,
More informationCounterfeit Drugs and Supply Chain Security
Counterfeit Drugs and Supply Chain Security Rick Mitzner Senior Director, Engineering Technology Pfizer, Inc. Interphex April 21, 2015 Tragic Consequences Not If But When and Where May 7, 2007 80 children
More informationLogistic Provider Qualification: prerequisites and SLA
Logistic Provider Qualification: prerequisites and SLA Summary of the Content Benchmarking comparable providers and services to cope with product and market requirements Pre-qualification Activities Operational
More informationTechnical Report No. 46 Last Mile: Guidance for Good Distribution Practices for Pharmaceutical Products to the End User
Technical Report No. 46 Last Mile: Guidance for Good Distribution Practices for Pharmaceutical Products to the End User 2009 Last Mile: Guidance For Good Distribution Practices For Pharmaceutical Products
More informationProduct serialization and traceability mandates. kpmg.com
Product serialization and traceability mandates kpmg.com 1 Product serialization and traceability mandates Increasing threats to patient safety from counterfeited, adulterated, and diverted pharmaceutical
More information<1079> GOOD STORAGE AND SHIPPING PRACTICES-General Chapters
US. Pharmacopoeia USP29 GOOD STORAGE AND SHIPPING PRACTICES-General Chapters 1079 GOOD STORAGE AND SHIPPING PRACTICES This general information chapter is intended to provide general guidance concerning
More informationCode of Practice for Holder of Certificate of Registration as an Importer and Exporter of Pharmaceutical Products
Code of Practice for Holder of Certificate of Registration as an Importer and Exporter of Pharmaceutical Products March 2014 Table of Content INTRODUCTION 3 Section 1: GENERAL RESPONSIBILITIES OF HOLDER
More informationInspection of API Manufacturers & Update on Registration Process
Inspection of API Manufacturers & Update on Registration Process Catherine Neary, GMP Inspector GMP Conference 7 February 2017 Dublin Presentation Contents HPRA Inspection Programme for API Manufacturers
More informationSTUDY REQUEST FORM AND TRAQ DSS FORM
Research Road Map April 2017 In This Issue Pharmacy Services for Research Study Request Form and TRAQ DSS FORM Management of Investigational Drugs Pharmacy Standard Operating Procedures IDS Team Qualifications
More information21CFR Ventilation, air filtration, air heating and cooling. 21CFR211 Details, Details. 21CFR Equipment Cleaning and Maintenance
21CFR211 Details, Details Kirsten L. Vadheim, Ph.D., RAC 7710 196th Avenue N.E. Redmond WA 98053 Tel: 651.260.6560 Fax: 425.868.4302 klvadheim@hotmail.com 21CFR211.46 Ventilation, air filtration, air heating
More informationIATA Chapter 17 Update on Changes. Donald Harrison, United Airlines Cargo
IATA Chapter 17 Update on Changes Donald Harrison, United Airlines Cargo Needs Identified Gap in the Cold Chain Airlines were identified as a broken link in the cold chain for transporting time and temperature
More informationThe ABCs and Challenges of GMP The American Experience
The ABCs and Challenges of GMP The American Experience The Canadian Association of Nuclear Medicine Toronto, Ontario April 22, 2017 Reiko Oyama, R.Ph., B.C.N.P. Washington University School of Medicine
More informationSupplier Assurance Program. CBE Pty Ltd
Supplier Assurance Program CBE Pty Ltd This training program is copyright to CBE Pty Ltd and may not be modified, reproduced, sold, loaned, hired or traded in any form without its express written permission.
More informationCGMP Requirements for Investigational Products
PREP #6 CGMP Requirements for Investigational Products Ji-Eun Kim, RPh, PhD Research Pharmacist Regulatory Affairs Office of Research Compliance December 6, 2016 1 CME Disclosure Statement Northwell Health
More informationAgenda. What is considered as perishable? Food vs. Pharma: similarities and differences. Transportation & Infrastructure Requirements
Mr. Ingo Ocklenburg Mr. Michael Vorwerk Mr. Patrick Güth Agenda What is considered as perishable? Food vs. Pharma: similarities and differences Packaging and Handling Regulatory Requirements Transportation
More informationDrug Products, Labeling, and Packaging
442 Pharmaceutical Industry: Drug Products, Labeling, and Packaging Positions Drug Products, Labeling, and Packaging Ready-to-Administer Packaging for Hazardous Drug Products Intended for Home Use (1711)
More informationBrussels Airport Gateway for the time and temperature controlled supply chain
Brussels Airport Gateway for the time and temperature controlled supply chain Nathan De Valck Cargo Account manager Central location in Europe Brussels, a top European Logistics Hub, in the political,
More informationOverview sulla nuova guideline GDP
AFTI 09 febbraio 2012 Overview sulla nuova guideline GDP Fabio Dotto Ispettorato Regionale Medicamenti Svizzera del Sud 1 113 GDP Guidelines GDP of Medicinal Products for Human Use Public consultation
More informationTITLE: Research Pharmacy Standard Policy SOP #: INV-100 Page: 1 of 5 Effective Date: 8/31/17
SOP #: INV-100 Page: 1 of 5 1. POLICY STATEMENT: DF/HCC research pharmacies follow a standard set of policy requirements for clinical trials. 2. BACKGROUND: None 3. RESPONSIBLE PERSONNEL: 3.1. Research
More informationTimeline for the Drug Supply Chain and Security Act
April 2014 Timeline for the Drug Supply Chain and Security Act (Title II, Drug Quality and Security Act, 2013) Overview The Drug Supply Chain and Security Act (Title II, Drug Quality and Security Act,
More informationValidation and Verification of Supply Chain: End-to-End Karen S Ginsbury For IVT: Workshop C 28 October :30 12:00
Validation and Verification of Supply Chain: End-to-End Karen S Ginsbury For IVT: Workshop C 28 October 2014 08:30 12:00 Pangea 7 May 2014 Israel ONLY Pangea 7 May 2014 Israel ONLY Pangea 7 May 2014 Israel
More informationGUIDELINES ON GOOD DISTRIBUTION PRACTICES FOR PHARMACEUTICAL PRODUCTS
DRAFT VERSION GUIDELINES ON GOOD DISTRIBUTION PRACTICES FOR PHARMACEUTICAL PRODUCTS Published on the website of www.cdsco.nic.in on 10/01/2013 Notification The following draft guideline is hereby published
More informationThe Quality Agreement evolved to fill these gaps and address these challenges.
A Model for Pharmaceutical Supply Chain Quality Agreements Rafik H. Bishara, Steve Jacobs, and Dan Bell The Evolution of the Quality Agreement Over a decade ago, the way business was conducted between
More informationGLOBAL HEALTH SUPPLY CHAIN QUALITY ASSURANCE QA.APP.GEN-52 Laboratory Commodities and Consumables: Supplier Technical Questionnaire
GLOBAL HEALTH SUPPLY CHAIN QUALITY ASSURANCE Laboratory Commodities and Consumables: Supplier Technical Questionnaire This questionnaire is used to collect information from offerors of Laboratory Commodities
More informationAide-Memoire on Product Return: A Risk-based Rationale for Inspecting Returns and its Impacts on GDP Compliance Assessment
Aide-Memoire on Product Return: A Risk-based Rationale for Inspecting Returns and its Impacts on GDP Compliance Assessment Glaucia Karime Braga, Ph.D. USP Packaging and Distribution Expert Committee Member
More informationQuality in Global Sourcing
Quality in Global Sourcing Steve Greer Global Compliance Leader P&G Beauty & Grooming Current Challenges 1 Supplier Related Incidents High profile material contamination incidents have highlighted risks
More informationInspection Trends. American Society for Quality Richmond, VA Section March 8, 2016
Inspection Trends American Society for Quality Richmond, VA Section March 8, 2016 Brooke K. Higgins, Senior Policy Advisor CDER / Office of Compliance Office of Manufacturing Quality Division of Drug Quality
More informationEffective Risk Management A Catalyst For Quality Performance
Page 1 of 6 Guest Column June 8, 2016 Effective Risk Management: A Catalyst For Quality Performance By Bikash Chatterjee, President and Chief Science Officer, Pharmatech Associates When we think of risk
More informationDeveloping a Robust Quality System to Assure Data Integrity
Developing a Robust Quality System to Assure Data Integrity Maryann Gribbin Chief Compliance Officer, Faith & Royale Consultants Co-Chair PDA Data Integrity Task Force Data Integrity Facts or information
More informationDrug Quality Assurance: Systems at ChemCon Author: Dr. Peter Gockel
Drug Quality Assurance: Systems at ChemCon Author: Dr. Peter Gockel On February 13th, 2006, the FOOD AND DRUG ADMINISTRATION (FDA) implemented a revision to the Compliance Program Guidance Manual for active
More informationOverview SFLGDP1. Develop, implement and maintain a quality system to control the distribution of medicinal products
Overview This standard is about developing, implementing and maintaining a quality system to control the. You will be responsible for developing the quality system and confirming colleagues understand
More informationQuality Agreements with CMO s. Presented at ASQ Orange Empire Meeting May 13, 2014 By Luke Foo Sr. Director QA/QC Spectrum Pharmaceuticals
Quality Agreements with CMO s Presented at ASQ Orange Empire Meeting May 13, 2014 By Luke Foo Sr. Director QA/QC Spectrum Pharmaceuticals FDA Guidance Contract Manufacturing Arrangements for Drugs: Quality
More informationAssuring Food Safety. Presented by Jill Hollingsworth, DVM Vice President, Food Safety Programs
Assuring Food Safety Presented by Jill Hollingsworth, DVM Vice President, Food Safety Programs Advancing American Competitiveness through Conformity Assessment: Legal Issues and Best Practices September
More informationQuality Systems and GMPin Pharmaceutical Manufacturing. Marleine Akl Quality Assurance Algorithm SAL
Session s Outline 1. Bio-equivalence 2. A 30-minute DVD on GMP Break 3. Quality Systems and GMPs in Pharmaceutical Manufacturing 4. Good Distribution Practices 5. Questionnaire (could not go through due
More informationHosting Inspections from foreign countries: PMDA (Japan) ANVISA (Brazil)
Hosting Inspections from foreign countries: PMDA (Japan) ANVISA (Brazil) Kathrin Abelein Vice President Quality, R-Pharm, JSC First Russian GMP Conference 20. 22. September 2016 Agenda General information
More informationC3M Continuous Cold Chain Management. Active Monitoring Solutions for the Pharmaceutical Industry. Validating Asset Integrity
C3M Continuous Cold Chain Management Active Monitoring Solutions for the Pharmaceutical Industry Key Benefits Comprehensive Information detailed data and dynamic mapping of temperature and humidity. Real
More informationCreating a Centralized Compounding Pharmacy within a Health System
SALAS BLANCAS Amy Benner, PharmD Director of Central and Shared Services Scripps Health. Robert Miller, MS Quality Manager Scripps Health Ensuring the production of accurate and safe sterile compounded
More informationBy Christoph Frick and Nicola Spiggelkötter. Creating a Master Plan for Drug Warehousing, Transportation and Distribution
By Christoph Frick and Nicola Spiggelkötter Creating a Master Plan for Drug Warehousing, Transportation and Distribution ISBN: 978-3-943267-93-8 Where a product trademark, registration mark, or other protected
More informationNew GMPs for Active Substances & Excipients. Presented by Eoin Hanley 4 July, 2016
New GMPs for Active Substances & Excipients Presented by Eoin Hanley 4 July, 2016 What we will cover in this session The changing landscape EC Guideline on principles of GDP of active substances Formalised
More informationPrequalification Team WHO PUBLIC INSPECTION REPORT Vaccine Manufacturer
Part 1: General information Name of Manufacturer Production Block Physical address Contact address Prequalification Team WHO PUBLIC INSPECTION REPORT Vaccine Manufacturer. Clean Utilities in the Basement.
More informationQuality Risk Management (QRM) of active pharmaceutical ingredients during transportation by using FMEA tools and methodology
PharmaTutor PRINT ISSN: 294-6679 E-ISSN: 247-788 2 Quality Risk Management (QRM) of active pharmaceutical ingredients during transportation by using FMEA tools and methodology Upendra Kumar Singh*, Sammer
More informationTop Annual 483 Observations: The Cycle of Quality June 2017 Presented by: Susan Schniepp
Top Annual 483 Observations: The Cycle of Quality June 2017 Presented by: Susan Schniepp 2016 Regulatory Compliance Associates Inc. Top Observation for 5 years Year Drugs #1 citation Device #1 citation
More informationTaking a Leap Toward Global Supply Chain Efficiency - Part II
Taking a Leap Toward Global Supply Chain Efficiency - Part II 2 Supply Chain Brochure - Part II INTRODUCTION Pharmaceutical manufacturers face a number of challenges in the production and delivery of medicinal
More informationTrinity College Dublin QP Forum 2017 Tuesday 25 th April
Trinity College Dublin QP Forum 2017 Tuesday 25 th April HPRA QUESTIONS & ANSWERS 1. What is the approach being taken for audit of contamination control strategies as per chapters 3 & 5? What is the current
More informationPOLICY Investigational Drug Service Transport
Investigational Drug Service Huntsman Cancer Hospital 1950 Circle of Hope, Suite 2110 Salt Lake City, Utah 84112 POLICY Investigational Drug Service Transport Purpose A. This policy establishes procedures
More informationSan Jose, California, USA
Glisland, Inc. San Jose, California, USA http://www.glisland.com Welcome to the Drug GMP World Current Good Manufacturing Practice cgmp ICH Q10 Pharmaceutical Quality System PQS GMP QSR Quality System
More informationInspections, Compliance, Enforcement, and Criminal Investigations
Seite 1 von 10 Inspections, Compliance, Enforcement, and Criminal Investigations Laboratoire Atlas Inc. 6/25/09 hhsbluebird Department of Health and Human Services Public Health Service Food and Drug Administration
More informationSUPPLIER FOOD SAFETY ASSURANCE
Chapter 12 SUPPLIER FOOD SAFETY ASSURANCE 1.0 PARTS OF A SUPPLIER FOOD SAFETY ASSURANCE PROGRAM 2.0 CHOOSING SUPPLIERS 2.1 Supplier Approval 2.2 Approved Supplier List 3.0 PRODUCT SPECIFICATIONS AND CONTROLS
More informationHow does the GDP guidelines impacted DGF on Local and Global level. 25 june 2013
How does the GDP guidelines impacted DGF on Local and Global level. 25 june 2013 Overview Introduction Who is DHL? What is GDP? DGF services Global approach DGF services Belgium 2 Introduction Elledin
More informationPharma Market Growth and The Cost of Doing Business
Pharma Market Growth and The Cost of Doing Business May X, 2010 Agenda Pharma Market Overview Pharma Market Trends Cold Chain Complexities Freight Overview Pharma Costs and the Cost of Loss and Excursions
More informationTime & Temperature Logistics for Healthcare Products
Time & Temperature Logistics for Healthcare Products Reality Check - A Non-Traditional Approach 2010 CNS Partnership Conference May 4, 2010 Christofer Matney Air Service Director Indianapolis International
More informationGlobal Integrated Solutions. Advanced Therapy Clinical Development and Commercialization
Global Integrated Solutions Advanced Therapy Clinical Development and Commercialization There There is is a patient patient waiting. waiting. Fisher BioServices ensures that your advanced therapy product
More informationBuilding Effective National Strategies to Better Address Counterfeit Medicines
Building Effective National Strategies to Better Address Counterfeit Medicines Expanding GMP, GDP, GPP, and Pharmacovigilance Systems ILISA B.G. BERNSTEIN, Pharm.D., J.D. Director of Pharmacy Affairs U.S.
More informationMHRA GDP Symposium. Novotel London West, London 8 & 10 December #GMDPevents
MHRA GDP Symposium Novotel London West, London 8 & 10 December 2015 Deficiencies in GDP Phil Neale, GDP Operations Manager Tony Orme, GDP Senior Inspector. Finding deficiencies in GDP is not only for those
More informationMahendra Chemicals 7/13/15
Mahendra Chemicals 7/13/15 Department of Health and Human Services Public Health Service Food and Drug Administration Silver Spring, MD 20993 CERTIFIED MAIL RETURN RECEIPT REQUESTED July 13, 2015 Mr. Rajnibhai
More informationDeficiencies found in Inspections and QP Responsibilities
Deficiencies found in Inspections and QP Responsibilities Ciara Turley, HPRA Inspector QP Forum, Trinity College, Dublin 25 th April 2017 Dublin Key QP Responsibilities Chapter 1, 1.4 (xv) Medicinal products
More informationGMP Inspection Deficiencies Review of Deficiencies Observed in 2013.
GMP Inspection Deficiencies 2013 Review of Deficiencies Observed in 2013. Executive Summary The most frequently encountered defect categories raised over the previous five years have remained relatively
More informationInspection-Ready IRT. Valarie Higgins President & Managing Director Almac Clinical Technologies.
Inspection-Ready IRT Valarie Higgins President & Managing Director Almac Clinical Technologies www.almacgroup.com 2 Biologics License Application and the IRT Provider IRT 3 Agenda Why is IRT Becoming an
More informationYour Partner Of Choice For Global Pharma Compliance. Corporate Presentation
Your Partner Of Choice For Global Pharma Compliance. Corporate Presentation Vision We aspire to be a partner of choice for global compliance & project management across the pharmaceutical value chain,
More informationA PROCESS VALIDATION GUIDE FOR COLD CHAIN LOGISTICS: ENSURING COMPLIANCE GLOBALLY
A PROCESS VALIDATION GUIDE FOR COLD CHAIN LOGISTICS: ENSURING COMPLIANCE GLOBALLY Presented by: Gary Hutchinson, President, Modality Solutions 8 th BSMA Conference Preparing the Biotech Supply Chain for
More informationS P O N S O R E D B Y
S P O N S O R E D B Y The Value of Visibility Data Seeing and Benefiting from Data after its Capture Example: Preparing for Serialization and Pedigree within the U.S. Pharmaceutical Supply Chain Agenda
More informationGood Manufacturing Practices Purpose and Principles of GMP. Tony Gould
Good Manufacturing Practices Purpose and Principles of GMP Tony Gould Why GMP? Provides a high level assurance that medicines are manufactured in a way that ensures their safety, efficacy and quality Medicines
More informationHealth Care Logistics: an Enabler of Change BioLogistics in a Changing Healthcare World Northwestern University Transportation Center
Health Care Logistics: an Enabler of Change BioLogistics in a Changing Healthcare World Northwestern University Transportation Center Dave Bode VP, Health Care Solutions DSC Logistics April 20, 2016 Health
More informationOverview SFLGDP1- HP Develop, implement and maintain a quality system to control the distribution of medicinal products
- HP97 04 Overview What this standard is about This standard is about developing, implementing and maintaining a quality system to control the. You will be responsible for developing the quality system
More informationPrequalification Team Inspection services WHO PUBLIC INSPECTION REPORT (WHOPIR) Finished Product Manufacturer. Tablets
Prequalification Team Inspection services WHO PUBLIC INSPECTION REPORT (WHOPIR) Finished Product Manufacturer Part 1: information about the inspection Name of manufacturer Physical address production departments
More informationInformation Technology Trends and Best Practices The Industrial Internet of Things, Blockchain and Smart Contracts
Information Technology Trends and Best Practices The Industrial Internet of Things, Blockchain and Smart Contracts Bob Celeste, Founder Center for Supply Chain Studies Neutral, Non-Profit, 501(c)(6) Exploration
More informationTemperature Monitoring (Clinical Trials)
York Foundation Trust R&D Unit Standard Operating Procedure Pharm/S48 Temperature Monitoring (Clinical Trials) IT IS THE RESPONSIBILITY OF ALL USERS OF THIS SOP TO ENSURE THAT THE CORRECT VERSION IS BEING
More informationBeing Prepared for Track and Trace: DSCSA 101
Being Prepared for Track and Trace: DSCSA 101 Susanne Somerville, Founder The LinkLab Eric Garvin, Founder, The LinkLab Brian Daleiden, VP Industry Marketing and Co-Founder, TraceLink Objective of Today
More informationPOST IMPORTATION TESTING
POST IMPORTATION TESTING SAPRAA MEETING Karen Ford BYTES CONFERENCE CENTRE, MIDRAND 17 November 2017 Thomas Edison said : There is always a better way! 2 POST IMPORTATION TESTING EXEMPTION =PITE 3 OVERVIEW
More informationCSafe Utilization in a Quality Management System. Scott Garchar Manager - Global Business Development FedEx Custom Critical
CSafe Utilization in a Quality Management System Scott Garchar Manager - Global Business Development FedEx Custom Critical Agenda CSafe Relationship History Current State Review Quality Management System
More informationIncreasing Focus on Excipients
The New Paradigm for Excipient Qualification and Supply Chain Control IPEC Update David R. Schoneker Director of Global Regulatory Affairs - Colorcon Chairman International Pharmaceutical Excipients Council
More informationClinical Trial Unit, Hospital Pharmacy Central Denmark Region
Clinical Trial Unit, Hospital Pharmacy Central Denmark Region Letter of Introduction The aim of this Letter of Introduction is to clarify general guidelines for working with the Hospital Pharmacy Central
More information(Information) INFORMATION FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES EUROPEAN COMMISSION
21.3.2015 EN Official Journal of the European Union C 95/1 II (Information) INFORMATION FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES EUROPEAN COMMISSION Guidelines of 19 March 2015 on
More informationUNICEF s Quality Assurance System for Procurement of Finished Pharmaceutical Products
UNICEF s Quality Assurance System for Procurement of Finished Pharmaceutical Products UNICEF Industry Consultation with Manufacturers and Suppliers of Finished Pharmaceutical Products 29 th 30 th September
More informationControl of the Last Mile to ensure end-to-end compliance and protection of our products. Maurizio Caschera QA Manager
Control of the Last Mile to ensure end-to-end compliance and protection of our products Maurizio Caschera QA Manager Arena International Cannes 26-27 /02/2015 1 CO00993(1) Sanofi Pasteur MSD SNC au capital
More informationFSMA s New Sanitary Transportation Rule: How to Prepare Your Game Plan for Compliance
FSMA s New Sanitary Transportation Rule: How to Prepare Your Game Plan for Compliance Speakers: Holly Mockus & Laura McMillan April 20, 2016 Today s Speakers Laura McMillan Vice President Training Development
More informationTest item OECD guideline No 19
Test item OECD guideline No 19 Advisory Document of the Working Group on Good Laboratory Practice on the Management, Characterisation and Use of Test Items sophie.svensson@swedac.se Agenda Background Definitions
More informationDesigning solutions for healthcare shippers
Bio Supply Management Alliance Conference Foster City, California (USA) October 8, 2013 Designing solutions for healthcare shippers Technical Fellow, Cold Chain Management Life Sciences & Specialty Services,
More informationEuropean Union (EU) Regulatory Trends in GMP. Clive Brading Tianjin, China September 23, 2009
European Union (EU) Regulatory Trends in GMP Clive Brading Tianjin, China September 23, 2009 -2- Presentation Topics EU Background Inspections outside the EU EMEA Inspection Outcomes Dedicated Facilities
More informationChicago, The Gwen Hotel, 21 September HPCLC; Chicago, IL, USA; 21 September 2016
Chicago, The Gwen Hotel, 2 September 206 2 September 206 Background: The impact of mode shift on pharmaceutical logistics The pharmaceutical industry has relied heavily on the airline industry for its
More informationInspection. Implementation of ICH Q8, Q9, Q10
Implementation of ICH Q8, Q9, Q10 International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use Outline Aim of - as a key part of the regulatory
More informationICH Quality Implementation Working Group POINTS TO CONSIDER
ICH Quality Implementation Working Group POINTS TO CONSIDER ICH-Endorsed Guide for ICH Q8/Q9/Q10 Implementation Document date: 16 June 2011 International Conference on Harmonisation of Technical Requirements
More informationAdvancing GDP Compliance Standards In Airline Transportation: Raising the QA Bar for Biopharma. Chris Fore Compliance Manager
Advancing GDP Compliance Standards In Airline Transportation: Raising the QA Bar for Biopharma Chris Fore Compliance Manager 9th BSMA Conference Foster City, CA 10/20/2016 Introduction There has been an
More information